Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fahima Nekka

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Pharmacology|August 5, 2021
A Quantitative Systems Pharmacology Framework for Optimal Doxorubicin Granulocyte Colony-Stimulating Factor Regimens in Triple-Negative Breast CancerRosalba Vivian Paredes Bonilla, Fahima Nekka, Morgan Craig
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 22, 2022
Critical assessment of the revised guidelines for vancomycin therapeutic drug monitoringAbdullah Aljutayli, Daniel J G Thirion, Fahima Nekka
Theoretical Biology & Medical Modelling|June 30, 2009
Antimicrobial breakpoint estimation accounting for variability in pharmacokineticsGoue Denis Gohore Bi, Jun Li, Fahima Nekka
International Journal of Molecular Sciences|April 12, 2022
Phasic Dopamine Changes and Hebbian Mechanisms during Probabilistic Reversal Learning in Striatal Circuits: A Computational StudyMiriam Schirru, Florence Véronneau-Veilleux, Fahima Nekka, et al.
Frontiers in Computational Neuroscience|August 4, 2022
A mechanistic model of ADHD as resulting from dopamine phasic/tonic imbalance during reinforcement learningFlorence Véronneau-Veilleux, Philippe Robaey, Mauro Ursino, et al.
Chaos (Woodbury, N.Y.)|January 26, 2024
Dynamical behavior-based approach for the evaluation of treatment efficacy: The case of immuno-oncologyDidier Zugaj, Frédérique Fenneteau, Pierre-Olivier Tremblay, et al.
Journal of Pharmacokinetics and Pharmacodynamics|October 21, 2020
An integrative model of Parkinson's disease treatment including levodopa pharmacokinetics, dopamine kinetics, basal ganglia neurotransmission and motor action throughout disease progressionFlorence Véronneau-Veilleux, Philippe Robaey, Mauro Ursino, et al.
Clinical Pharmacokinetics|October 21, 2021
An Update on Population Pharmacokinetic Analyses of Vancomycin, Part II: In Pediatric PatientsAbdullah Aljutayli, Ibrahim El-Haffaf, Amélie Marsot, et al.
Journal of Child and Adolescent Psychopharmacology|February 7, 2017
An Evaluation Approach for the Performance of Dosing Regimens in Attention-Deficit/Hyperactivity Disorder TreatmentGuillaume Bonnefois, Philippe Robaey, Olivier Barrière, et al.
Neurobiology of Learning and Memory|September 13, 2024
Valence-dependent dopaminergic modulation during reversal learning in Parkinson's disease: A neurocomputational approachMauro Ursino, Silvana Pelle, Fahima Nekka, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Pharmacology|August 5, 2021
A Quantitative Systems Pharmacology Framework for Optimal Doxorubicin Granulocyte Colony-Stimulating Factor Regimens in Triple-Negative Breast CancerRosalba Vivian Paredes Bonilla, Fahima Nekka, Morgan Craig
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 22, 2022
Critical assessment of the revised guidelines for vancomycin therapeutic drug monitoringAbdullah Aljutayli, Daniel J G Thirion, Fahima Nekka
Theoretical Biology & Medical Modelling|June 30, 2009
Antimicrobial breakpoint estimation accounting for variability in pharmacokineticsGoue Denis Gohore Bi, Jun Li, Fahima Nekka
International Journal of Molecular Sciences|April 12, 2022
Phasic Dopamine Changes and Hebbian Mechanisms during Probabilistic Reversal Learning in Striatal Circuits: A Computational StudyMiriam Schirru, Florence Véronneau-Veilleux, Fahima Nekka, et al.
Frontiers in Computational Neuroscience|August 4, 2022
A mechanistic model of ADHD as resulting from dopamine phasic/tonic imbalance during reinforcement learningFlorence Véronneau-Veilleux, Philippe Robaey, Mauro Ursino, et al.
Chaos (Woodbury, N.Y.)|January 26, 2024
Dynamical behavior-based approach for the evaluation of treatment efficacy: The case of immuno-oncologyDidier Zugaj, Frédérique Fenneteau, Pierre-Olivier Tremblay, et al.
Journal of Pharmacokinetics and Pharmacodynamics|October 21, 2020
An integrative model of Parkinson's disease treatment including levodopa pharmacokinetics, dopamine kinetics, basal ganglia neurotransmission and motor action throughout disease progressionFlorence Véronneau-Veilleux, Philippe Robaey, Mauro Ursino, et al.
Clinical Pharmacokinetics|October 21, 2021
An Update on Population Pharmacokinetic Analyses of Vancomycin, Part II: In Pediatric PatientsAbdullah Aljutayli, Ibrahim El-Haffaf, Amélie Marsot, et al.
Journal of Child and Adolescent Psychopharmacology|February 7, 2017
An Evaluation Approach for the Performance of Dosing Regimens in Attention-Deficit/Hyperactivity Disorder TreatmentGuillaume Bonnefois, Philippe Robaey, Olivier Barrière, et al.
Neurobiology of Learning and Memory|September 13, 2024
Valence-dependent dopaminergic modulation during reversal learning in Parkinson's disease: A neurocomputational approachMauro Ursino, Silvana Pelle, Fahima Nekka, et al.
Pageof 6